These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28931602)
1. An Anti-Inflammatory Role for NLRP10 in Murine Cutaneous Leishmaniasis. Clay GM; Valadares DG; Graff JW; Ulland TK; Davis RE; Scorza BM; Zhanbolat BS; Chen Y; Sutterwala FS; Wilson ME J Immunol; 2017 Oct; 199(8):2823-2833. PubMed ID: 28931602 [TBL] [Abstract][Full Text] [Related]
2. Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration. Krishnaswamy JK; Singh A; Gowthaman U; Wu R; Gorrepati P; Sales Nascimento M; Gallman A; Liu D; Rhebergen AM; Calabro S; Xu L; Ranney P; Srivastava A; Ranson M; Gorham JD; McCaw Z; Kleeberger SR; Heinz LX; Müller AC; Bennett KL; Superti-Furga G; Henao-Mejia J; Sutterwala FS; Williams A; Flavell RA; Eisenbarth SC Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3056-61. PubMed ID: 25713392 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan. Halliday A; Bates PA; Chance ML; Taylor MJ Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391 [TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis. Fritzsche C; Schleicher U; Bogdan C Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313 [TBL] [Abstract][Full Text] [Related]
5. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Liese J; Schleicher U; Bogdan C Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422 [TBL] [Abstract][Full Text] [Related]
6. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous Manifestations of Human and Murine Leishmaniasis. Scorza BM; Carvalho EM; Wilson ME Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629171 [TBL] [Abstract][Full Text] [Related]
8. NLRP10 Affects the Stability of Abin-1 To Control Inflammatory Responses. Mirza N; Sowa AS; Lautz K; Kufer TA J Immunol; 2019 Jan; 202(1):218-227. PubMed ID: 30510071 [TBL] [Abstract][Full Text] [Related]
9. The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain. Ritter U; Mattner J; Rocha JS; Bogdan C; Körner H Microbes Infect; 2004 May; 6(6):559-65. PubMed ID: 15158189 [TBL] [Abstract][Full Text] [Related]
10. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. Wershil BK; Theodos CM; Galli SJ; Titus RG J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970 [TBL] [Abstract][Full Text] [Related]
11. Epidermal NLRP10 contributes to contact hypersensitivity responses in mice. Damm A; Giebeler N; Zamek J; Zigrino P; Kufer TA Eur J Immunol; 2016 Aug; 46(8):1959-69. PubMed ID: 27221772 [TBL] [Abstract][Full Text] [Related]
12. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA. von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504 [TBL] [Abstract][Full Text] [Related]
14. Skin dendritic cells in murine cutaneous leishmaniasis. Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222 [TBL] [Abstract][Full Text] [Related]
15. TNF controls the infiltration of dendritic cells into the site of Leishmania major infection. Ritter U; Lechner A; Scharl K; Kiafard Z; Zwirner J; Körner H Med Microbiol Immunol; 2008 Mar; 197(1):29-37. PubMed ID: 17661079 [TBL] [Abstract][Full Text] [Related]
16. Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection. Baldwin T; Sakthianandeswaren A; Curtis JM; Kumar B; Smyth GK; Foote SJ; Handman E Parasite Immunol; 2007 Oct; 29(10):501-13. PubMed ID: 17883453 [TBL] [Abstract][Full Text] [Related]
17. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Eisenbarth SC; Williams A; Colegio OR; Meng H; Strowig T; Rongvaux A; Henao-Mejia J; Thaiss CA; Joly S; Gonzalez DG; Xu L; Zenewicz LA; Haberman AM; Elinav E; Kleinstein SH; Sutterwala FS; Flavell RA Nature; 2012 Apr; 484(7395):510-3. PubMed ID: 22538615 [TBL] [Abstract][Full Text] [Related]
18. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Wilhelm P; Wiede F; Meissner A; Donhauser N; Bogdan C; Körner H Microbes Infect; 2005 Dec; 7(15):1461-8. PubMed ID: 16269265 [TBL] [Abstract][Full Text] [Related]
19. c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection. Reinhard K; Huber M; Wostl C; Hellhund A; Toboldt A; Abass E; Casper B; Joeris T; Herr C; Bals R; Steinhoff U; Lohoff M; Visekruna A Eur J Immunol; 2011 May; 41(5):1388-98. PubMed ID: 21469108 [TBL] [Abstract][Full Text] [Related]
20. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients. Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]